Clinical development approaches

Current research processes and infrastructure can’t fully support the requirements of cell and gene therapy protocol development and delivery. Now is the time for new approaches, to futureproof clinical development as the product pipeline continues to grow. This section offers a vision for how stakeholders could collaborate to expand the number of CAGT clinical research sites, and a case study of how advanced analytics support clinical development.

Download the executive summary